Concepedia

Michael Ezrokhi

ME

Statistics

Publications

13

Citations

511

H-Index

12

Active since

2007

Affiliations

Veroscience (United States)(Current)

Harvard University

Brigham and Women's Hospital

Eastern Virginia Medical School

The University of Texas Health Science Center at San Antonio

Michael Ezrokhi is an author at Veroscience (United States) specializing in molecular pharmacology, medicine, and pharmacology.

Top concepts

Publications per year

2007–2022

13

Publications

13

Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes

J. Michael Gaziano, Anthony H. Cincotta, Christopher M. O’Connor et al. · Diabetes Care · 2010 · 210 citations · Full text

A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset™ or placebo

Richard E. Scranton, J. Michael Gaziano, Dean Rutty et al. · BMC Endocrine Disorders · 2007 · 55 citations · Full text

Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats

Michael Ezrokhi, Shuqin Luo, Yelena Trubitsyna et al. · Diabetology & Metabolic Syndrome · 2014 · 39 citations · Full text

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus

Bindu Chamarthi, J. Michael Gaziano, Lawrence Blonde et al. · Journal of Diabetes Research · 2015 · 34 citations · Full text

Effect of Bromocriptine-Qr On Glycemic Control in Subjects with Uncontrolled Hyperglycemia On One or Two Oral Anti-Diabetes Agents

Aaron I. Vinik, Anthony H. Cincotta, Richard E. Scranton et al. · Endocrine Practice · 2012 · 33 citations

, , +10

1–5 of 13